Syngene

Syngene International, established in 1993, is a leading contract research and manufacturing organization (CRMO) headquartered in India. Operating within the Business Services sector, Syngene provides integrated end-to-end discovery, development, and manufacturing services. Its core expertise spans medicinal chemistry, biology, toxicology, process R&D, custom synthesis, and cGMP manufacturing and formulation. Syngene serves global pharmaceutical, biotechnology, nutrition, cosmetic, and specialty healthcare industries, acting as a critical partner for advancing R&D pipelines through innovation and comprehensive service offerings.

The organization operates with a significant scale, employing 5,000 to 10,000 professionals across 10 locations. This extensive workforce, including numerous scientists and engineers, enables Syngene to manage complex projects efficiently. Meet Syngene's team to gain insight into the leadership and expertise driving these advanced research and manufacturing capabilities. Syngene's dedication to quality and regulatory compliance is underscored by its cGMP manufacturing facilities, supporting clients from initial discovery phases through to commercial product launch.

Trading under the ticker NSE: SYNGENE, the company is a notable entity in the market. Syngene's service portfolio includes molecular discovery, library design, analytical services, and pharmacovigilance. By delivering integrated, end-to-end solutions, Syngene International plays a crucial role in accelerating drug development and bringing novel products to market, solidifying its position as a leading CRMO in Asia and globally.